Combining research approaches to advance our understanding of drug addiction

Current Psychiatry Reports

Volumn 7, Issue 2, 2005, Pages 125-132

  van den Bree, Marianne B M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; ALCOHOL DEHYDROGENASE; AMINE OXIDASE (FLAVIN CONTAINING); BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; ILLICIT DRUG; NEUROPEPTIDE Y; OPIATE; SEROTONIN; SEROTONIN TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

ADOPTION; AWARENESS; BEHAVIOR DISORDER; BRAIN REGION; COMORBIDITY; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE NEED; HEREDITY; HUMAN; MEDICAL RESEARCH; MOLECULAR GENETICS; NEUROTRANSMISSION; NONHUMAN; ONSET AGE; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; SUBSTANCE ABUSE; TWINS;

EID: 20444429740     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-005-0009-4     Document Type: Review

References (73)

1. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994:175-195.
2. Chao J, Nestler EJ: Molecular neurobiology of drug addiction. Annu Rev Med 2004, 55:113-132.
3. European Monitoring Centre for Drugs and Alcohol Addiction (EMCDDA): Annual report on the drug situation in the EU and Norway 2003. Luxembourg: Office for Official Publications for the European Communities; 2003.
4. The UK report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The UK Drug Situation 2001. Drugscope; http://www.drugscope.org.uk/druginfo/drugreport.asp.2001.
5. Leshner AI, Koob GF: Drugs of abuse and the brain. Proc Assoc Am Physicians 1999, 111:99-108.
6. Fasano S, Brambilla R: Cellular mechanisms of striatum-dependent behavioral plasticity and drug addiction. Curr Mol Med 2002, 2:649-665.
7. Kreek MJ, LaForge KS, Butelman E: Pharmacotherapy of addictions. Nat Rev Drug Discov 2002, 1:710-726.
8. Koob GF, Ahmed SH, Boutrel B, et al.: Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 2004, 27:739-749.
9. Nestler EJ: Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001, 2:119-128.
10. Sklair-Tavron L, Shi WX, Lane SB, et al.: Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A 1996, 93:11202-11207.
11. Brambilla R: Targeting Ras/ERK signaling in the striatum: will it help? Mol Psychiatry 2003, 8:366-368.
12. Committee on Addictions of the Group for the Advancement of Psychiatry: Responsibility and choice in addiction. Psychiatr Serv 2002, 53:707-713.
13. Tsuang MT, Bar JL, Harley RM, Lyons MJ: The Harvard Twin Study of Substance Abuse: what we have learned. Harv Rev Psychiatry 2001, 9:267-279.
14. Van den Bree MB, Johnson EO, Neale MC, Pickens RW: Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend 1998, 52:231-241.
15. Kendler KS: Twin studies in psychiatric illness: An update. Arch Gen Psychiatry 2001, 58:1005-1014.
16. Tsuang MT, Lyons MJ, Meyer JM, et al.: Co-occurrence of abuse of different drugs in men: the role of drug- specific and shared vulnerabilities. Arch Gen Psychiatry 1998, 55:967-972.
17. Karkowski LM, Prescott CA, Kendler KS: Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs. Am J Med Genet 2000, 96:665-670.
18. Kendler KS, Jacobson KC, Prescott CA, Neale MC: Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003, 160:687-695.
19. Miles DR, van den Bree MB, Pickens RW: Sex differences in shared genetic and environmental influences between conduct disorder symptoms and marijuana use in adolescents. Am J Med Genet 2002, 114:159-168.
20. Kendler KS, Prescott CA, Myers J, Neale MC: The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 2003, 60:929-937.
21. Hicks BM, Krueger RE, Iacono WG, et al.: Family transmission and heritability of externalizing disorders: a twin-family study. Arch Gen Psychiatry 2004, 61:922-928.
22. Fu Q, Heath AC, Bucholz KK, et al.: Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. Arch Gen Psychiatry 2002, 59:1125-1132.
23. Silberg J, Rutter M, D'Onofrio B, Eaves L: Genetic and environmental risk factors in adolescent substance use. J Child Psychol Psychiatry 2003, 4:664-676.
24. Cadoret RJ, Yates WR, Troughton E, et al.: Adoption study demonstrating two genetic pathways to drug abuse. Arch Gen Psychiatry 1995, 52:42-52.
25. Cloninger CR, Bohman M, Sigvardsson S: Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. Arch Gen Psychiatry 1981, 38:861-868.
26. Cloninger CR, Sigvardsson S, Gilligan SB, et al.: Genetic heterogeneity and the classification of alcoholism. Adv Alcohol Subst Abuse 1988, 7:3-16.
27. Van den Bree MBM, Johnson EO, Neale MC, et al.: Genetic analysis of diagnostic systems of alcoholism in males. Biol Psychiatry 1998, 43:139-145.
28. Van den Bree MB, Whitmer MD, Pickworth WB: Predictors of smoking development in a population-based sample of adolescents: a prospective study. J Adolesc Health 2004, 35:172-181.
29. Van den Bree MBM, Pickworth WB: Risk factors predicting changes in marijuana involvement in teenagers. Arch Gen Psychiatry 2005, 63:311-319.
30. Caspi A, Moffitt TE, Newman DL, et al.: Behavioral observations at age 3 years predict adult psychiatric disorders. Longitudinal evidence from a birth cohort. Arch Gen Psychiatry 1996, 53:1033-1039.
31. Brook JS, Balka EB, Gursen MD, et al.: Young adults' drug use: a 17-year longitudinal inquiry of antecedents. Psychol Rep 1997, 80:1235-1251.
32. Tarter RE, Kirisci L, Mezzich A, et al.: Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 2003, 160:1078-1085.
33. Van den Bree MB, Owen MJ: The future of psychiatric genetics. Ann Med 2003, 35:122-134.
34. Reich T, Edenberg HJ, Goate A, et al.: Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 1998, 81:207-15.
35. Long JC, Knowler WC, Hanson RL, et al.: Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet 1998, 81:216-221.
36. Foroud T, Bucholz KK, Edenberg HJ, et al.: Linkage of an alcoholism-related severity phenotype to chromosome 16. Alcohol Clin Exp Res 1998, 22:2035-2042.
37. Foroud T, Edenberg HJ, Goate A, et al.: Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. Alcohol Clin Exp Res 2000, 24:933-945.
38. Stallings MC, Corley RP, Hewitt JK, et al.: A genome-wide search for quantitative trait loci influencing substance dependence vulnerability in adolescence. Drug Alcohol Depend 2003, 70:295-307.
39. Uhl GR, Liu QR, Walther D, et al.: Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet 2001, 69:1290-1300.
40. Tyndale RF: Genetics of alcohol and tobacco use in humans. Ann Med 2003, 35:94-121.
41. Kreek MJ, Nielsen DA, LaForge KS: Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med 2004, 5:85-108.
42. Enoch MA: Pharmacogenomics of alcohol response and addiction. Am J Pharmacogenomics 2003, 3:217-232.
43. Murayama M, Matsushita S, Muramatsu T, Higuchi S: Clinical characteristics and disease course of alcoholics with inactive aldehyde dehydrogenase-2. Alcohol Clin Exp Res 1998, 22:524-527.
44. Neumark YD, Friedlander Y, Thomasson HR, Li TK: Association of the ADH2*2 allele with reduced ethanol consumption in Jewish men in Israel: a pilot study. J Stud Alcohol 1998, 59:133-139.
45. Tyndale RF, Droll KP, Sellers EM: Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics 1997, 7:375-379.
46. Ebstein RP, Novick O, Umansky R, et al.: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet 1996, 12:78-80.
47. Caspi A, Sugden K, Moffitt TE, et al.: Influence of life stress on depression: moderation by a polymorphism, in the 5-HTT gene. Science 2003, 301:386-389.
48. Brunner HG, Nelen M, Breakefield XO, et al.: Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993, 262:578-580.
49. Caspi A, McClay J, Moffitt TE, et al.: Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-854.
50. Zubieta JK, Heitzeg MM, Smith YR, et al.: COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.
51. Osier MV, Lu RB, Pakstis AJ, et al.: Possible epistatic role of ADH7 in the protection against alcoholism. Am J Med Genet 2004, 126B:19-22.
52. Bowers BJ, Owen EH, Collins AC, et al.: Decreased ethanol sensitivity and tolerance development in gamma-protein kinase C null mutant mice is dependent on genetic background. Alcohol Clin Exp Res 1999, 23:387-397.
53. Bergeson SE, Kyle Warren R, Crabbe JC, et al.: Chromosomal loci influencing chronic alcohol withdrawal severity. Mamm Genome 2003, 14:454-463.
54. Fernandez JR, Tarantino LM, Hofer SM, et al.: Epistatic quantitative trait loci for alcohol preference in mice. Behav Genet 2000, 30:431-437.
55. Foley DL, Eaves LJ, Wormley B, et al.: Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry 2004, 61:738-744.
56. Cutrona CE, Cadoret RJ, Suhr JA, et al.: Interpersonal variables in the prediction of alcoholism among adoptees: Evidence for gene-environment interactions. Compr Psychiatry 1994, 35:171-179.
57. Dick DM, Rose RJ, Viken RJ, et al.: Exploring gene-environment interactions: socioregional moderation of alcohol use. J Abnorm Psychol 2001, 110:625-632.
58. Roy MA, Walsh D, Prescott CA, Kendler KS: Biases in the diagnosis of alcoholism by the family history method. Alcohol Clin Exp Res 1994, 18:845-851.
59. Koopmans JR, Slutske WS, van Baal GC, Boomsma DI: The influence of religion on alcohol use initiation: evidence for genotype X environment interaction. Behav Genet 1999, 29:445-453.
60. Johnson V, Pandina RJ: Effects of the family environment on adolescent substance use, delinquency, and coping styles. Am J Drug Alcohol Abuse 1991, 17:71-88.
61. Fergusson DM, Horwood LJ: Prospective childhood predictors of deviant peer affiliations in adolescence. J Child Psychol Psychiatry 1999, 40:581-592.
62. Patterson GR, DeBaryshe BD, Ramsey E: A developmental perspective on antisocial behavior. Am Psychol 1989, 44:329-335.
63. Gold SR: The CAP control theory of drug abuse. NIDA Res Monogr 1980, 30:8-11.
64. Sillaber I, Rammes G, Zimmermann S, et al.: Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 2002, 296:931-933.
65. Miczek KA, Covington III HE, Nikulina Jr EM, et al.: Aggression and defeat: persistent effects on cocaine self-administration and gene expression in peptidergic and aminergic mesocorticolimbic circuits. Neurosci Biobehav Rev 2004, 27:787-802.
66. Barr CS, Schwandt ML, Newman TY, et al.: The use of adolescent nonhuman primates to model human alcohol intake: neurobiological, genetic, and psychological variables. Ann N Y Acad Sci 2004, 1021:221-233.
67. Ge X, Conger RD, Cadoret RJ, et al.: The developmental interface between nature and nurture: A mutual influence model of child antisocial behavior and parent behaviors. Developmental Psychology 1996, 32:574-589.
68. Chen K, Kandel DB, Davies M: Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. Drug Alcohol Depend 1997, 46:53-67.
69. Fergusson DM, Horwood LJ: Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997, 92:279-296.
70. Grant BF, Dawson DA: Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse 1998, 10:163-173.
71. DeWit DJ, Hance J, Offord DR, Ogborne A: The influence of early and frequent use of marijuana on the risk of desistance and of progression to marijuana-related harm. Prev Med 2000, 31:455-464.
72. Prescott CA, Kendler KS: Age at first drink and risk for alcoholism: a noncausal association. Alcohol Clin Exp Res 1999, 23:101-107.
73. Yoshimoto K, Hori M, Sorimachi Y, et al.: Increase of rat alcohol drinking behavior depends on the age of drinking onset. Alcohol Clin Exp Res 2002, 26:63S-65S.